mazindol has been researched along with Psychotic Disorders in 1 studies
Mazindol: Tricyclic anorexigenic agent unrelated to and less toxic than AMPHETAMINE, but with some similar side effects. It inhibits uptake of catecholamines and blocks the binding of cocaine to the dopamine uptake transporter.
Psychotic Disorders: Disorders in which there is a loss of ego boundaries or a gross impairment in reality testing with delusions or prominent hallucinations. (From DSM-IV, 1994)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carpenter, WT | 1 |
| Breier, A | 1 |
| Buchanan, RW | 1 |
| Kirkpatrick, B | 1 |
| Shepard, P | 1 |
| Weiner, E | 1 |
1 trial available for mazindol and Psychotic Disorders
| Article | Year |
|---|---|
Mazindol treatment of negative symptoms.
Topics: Adult; Analysis of Variance; Cross-Over Studies; Dopamine Uptake Inhibitors; Double-Blind Method; Fe | 2000 |